Sequential monitoring of intragraft cytokine mRNA expression in relation to diastolic left ventricular wall thickness and function early after heart transplantation

Clinical Transplantation

Volumn 16, Issue 6, 2002, Pages 433-441

  de Groot Kruseman, Hester A ^a   Baan, Carla C ^a   Hagman, Elly M ^a   Mol, Wendy M ^a   Niester, Hubert G ^a   Maat, Alex P ^a   Vantrimpont, Pascal J ^a   Zondervan, Pieter E ^a   Weimar, Willem ^a   Balk, Aggie H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute rejection; Cytokines echocardiography; Graft dysfunction; Heart transplantation

Indexed keywords

AZATHIOPRINE; BASIC FIBROBLAST GROWTH FACTOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATELET DERIVED GROWTH FACTOR A; STEROID; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; GENE EXPRESSION; HEART GRAFT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE RELAXATION; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CYTOKINES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VENTRICULAR FUNCTION, LEFT;

EID: 0036903801     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.02068.x     Document Type: Article

References (29)

1. MCNAMARA D, DI SALVO T, MATHIER M et al. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. J Heart Lung Transplant 1996: 15: 506.
2. ROSS HJ, GULLESTAD L, HUNT SA et al. Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. Circulation 1996: 94: II 289.
3. MILLS RM, NAFTEL DC, KIRKLIN JK et al. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 1997: 16: 813.
4. BARRY WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994: 89: 2421.
5. WILHELM MJ, PRATSCHKE J, BEATO F et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000: 102: 2426.
6. LUSTER AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Medical 1998: 338: 436.
7. VALANTINE H, JOHNSON F, DONG C et al. Cytokines as potential mediators of acute allograft diastolic dysfunction in cyclosporine-treated patients: a pilot study using in situ hybridization. Transplant Proc 1994: 26: 2852.
8. DENG MC, ERREN M, KAMMERLING L et al. The relation of interleukin-6, tumor necrosis factor-α, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995: 60: 1118.
9. DENG MC, ERREN M, ROEDER N et al. T-cell and monocyte subsets, inflammatory molecules, rejection and hemodynamics early after cardiac transplantation. Transplantation 1998: 65: 1255.
10. GRANT SCD, GUY SP, LAMB WR, BROOKS NH, BRENCHLEY PEC, HUTCHINSON IV. Expression of cytokine messenger RNA after heart transplantation: relationship with rejection and serum cytokines. Transplantation 1996: 62: 910.
11. TORRE-AMIONE G, MACLELLAN W, KAPADIA S et al. Tumor necrosis factor-α is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection. Transplant Proc 1998: 30: 875.
12. BILLINGHAM ME, CARY NR, HAMMOND ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990: 9: 587.
13. BAAN CC, HOLWEG CTJ, NIESTERS HGM et al. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant 1998: 17: 363.
14. KUMAR AG, BALLANTYNE CM, MICHAEL LH et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997: 95: 693.
15. STGOAR FG, GIBBONS R, SCHNITTGER I, VALANTINE HA, Popp RL. Left ventricular diastolic function. Doppler echocardiographic changes soon after cardiac transplantation. Circulation 1990: 83: 872.
16. VALANTINE HA. Rejection surveillance by Doppler echocardiography. J Heart Lung Transplant 1993: 12: 422.
17. DODD DA, BRADY LD, CARDEN KA et al. Pattern of echocardiographic abnormalities with acute cardiac allograft rejection in adults: correlation with endomyocardial biopsy. J Heart Lung Transplant 1993: 12: 1009.
18. MANNAERTS HE, BALK AH, SIMOONS ML et al. Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography. Br Heart J 1992: 68: 356.
19. MANNAERTS HE, SIMOONS ML, BALK AH et al. Pulsed-wave transmitral Doppler do not diagnose moderate acute rejection after heart transplantation. J Heart Lung Transplant 1993: 12: 411.
20. VALANTINE HA, YEOH TK, GIBBONS R et al. Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991: 10: 757.
21. SPES CH, SCHNAACK SD, SCHUTZ A et al. Serial Doppler echocardiographic assessment of left and right ventricular filling for non-invasive diagnosis of mild acute cardiac allograft rejection. Eur Heart J 1992: 13: 889.
22. JANSSEN PM, ZEITZ O, KEWELOH B et al. Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res 2000: 47: 99.
23. KELLY RA, SMITH TW. Cytokines and cardiac contractile function. Circulation 1997: 95: 778.
24. DENG MC, ROEDER N, PLENZ G et al. Proinflammatorische Zytokine und kardiale Pumpfunktion. Z Kardiol 1997: 86: 788.
25. HENNEIN HA, EBBA H, RODRIGUEZ JL et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994: 108: 626.
26. DENG MC, DASCH B, ERREN M, MOLLHOFF T, SCHELD HH. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 1996: 62: 184.
27. TORRE-AMIONE G, BOZKURT B, DESWAL A, MANN DL. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol 1999: 14: 206.
28. MELDRUM DR. Tumor necrosis factor in the heart. Am J Physiol 1998: 274: R577.
29. TORRE-AMIONE G, KAPADIA S, LEE J et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996: 93: 704.